Literature DB >> 19241120

Identification of novel target sites and an inhibitor of the dengue virus E protein.

Ragothaman Yennamalli1, Naidu Subbarao, Thorsten Kampmann, Ross P McGeary, Paul R Young, Bostjan Kobe.   

Abstract

Dengue and related flaviviruses represent a significant global health threat. The envelope glycoprotein E mediates virus attachment to a host cell and the subsequent fusion of viral and host cell membranes. The fusion process is driven by conformational changes in the E protein and is an essential step in the virus life cycle. In this study, we analyzed the pre-fusion and post-fusion structures of the dengue virus E protein to identify potential novel sites that could bind small molecules, which could interfere with the conformational transitions that mediate the fusion process. We used an in silico virtual screening approach combining three different docking algorithms (DOCK, GOLD and FlexX) to identify compounds that are likely to bind to these sites. Seven structurally diverse molecules were selected to test experimentally for inhibition of dengue virus propagation. The best compound showed an IC(50) in the micromolar range against dengue virus type 2.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19241120     DOI: 10.1007/s10822-009-9263-6

Source DB:  PubMed          Journal:  J Comput Aided Mol Des        ISSN: 0920-654X            Impact factor:   3.686


  48 in total

1.  Alpha-glucosidase inhibitors reduce dengue virus production by affecting the initial steps of virion morphogenesis in the endoplasmic reticulum.

Authors:  M P Courageot; M P Frenkiel; C D Dos Santos; V Deubel; P Desprès
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

Review 2.  Docking and scoring--theoretically easy, practically impossible?

Authors:  B Coupez; R A Lewis
Journal:  Curr Med Chem       Date:  2006       Impact factor: 4.530

3.  Fusion activity of flaviviruses: comparison of mature and immature (prM-containing) tick-borne encephalitis virions.

Authors:  F Guirakhoo; F X Heinz; C W Mandl; H Holzmann; C Kunz
Journal:  J Gen Virol       Date:  1991-06       Impact factor: 3.891

4.  Variable surface epitopes in the crystal structure of dengue virus type 3 envelope glycoprotein.

Authors:  Yorgo Modis; Steven Ogata; David Clements; Stephen C Harrison
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

5.  Oligomeric rearrangement of tick-borne encephalitis virus envelope proteins induced by an acidic pH.

Authors:  S L Allison; J Schalich; K Stiasny; C W Mandl; C Kunz; F X Heinz
Journal:  J Virol       Date:  1995-02       Impact factor: 5.103

6.  Protection of mice against Japanese encephalitis virus by passive administration with monoclonal antibodies.

Authors:  J Kimura-Kuroda; K Yasui
Journal:  J Immunol       Date:  1988-11-15       Impact factor: 5.422

Review 7.  The Role of histidine residues in low-pH-mediated viral membrane fusion.

Authors:  Thorsten Kampmann; Daniela S Mueller; Alan E Mark; Paul R Young; Bostjan Kobe
Journal:  Structure       Date:  2006-10       Impact factor: 5.006

8.  The utility of siRNA transcripts produced by RNA polymerase i in down regulating viral gene expression and replication of negative- and positive-strand RNA viruses.

Authors:  Matthew McCown; Michael S Diamond; Andrew Pekosz
Journal:  Virology       Date:  2003-09-01       Impact factor: 3.616

9.  ConSurf 2005: the projection of evolutionary conservation scores of residues on protein structures.

Authors:  Meytal Landau; Itay Mayrose; Yossi Rosenberg; Fabian Glaser; Eric Martz; Tal Pupko; Nir Ben-Tal
Journal:  Nucleic Acids Res       Date:  2005-07-01       Impact factor: 16.971

10.  Peptide inhibitors of dengue virus and West Nile virus infectivity.

Authors:  Yancey M Hrobowski; Robert F Garry; Scott F Michael
Journal:  Virol J       Date:  2005-06-01       Impact factor: 4.099

View more
  24 in total

1.  Probing the mechanism of pH-induced large-scale conformational changes in dengue virus envelope protein using atomistic simulations.

Authors:  Meher K Prakash; Alessandro Barducci; Michele Parrinello
Journal:  Biophys J       Date:  2010-07-21       Impact factor: 4.033

2.  Targeting domain-III hinging of dengue envelope (DENV-2) protein by MD simulations, docking and free energy calculations.

Authors:  Kshatresh Dutta Dubey; Gargi Tiwari; Rajendra Prasad Ojha
Journal:  J Mol Model       Date:  2017-03-02       Impact factor: 1.810

3.  Inhibitors of tick-borne flavivirus reproduction from structure-based virtual screening.

Authors:  Dmitry I Osolodkin; Liubov I Kozlovskaya; Evgenia V Dueva; Victor V Dotsenko; Yulia V Rogova; Konstantin A Frolov; Sergey G Krivokolysko; Ekaterina G Romanova; Alexey S Morozov; Galina G Karganova; Vladimir A Palyulin; Vladimir M Pentkovski; Nikolay S Zefirov
Journal:  ACS Med Chem Lett       Date:  2013-07-30       Impact factor: 4.345

4.  GNF-2 Inhibits Dengue Virus by Targeting Abl Kinases and the Viral E Protein.

Authors:  Margaret J Clark; Chandra Miduturu; Aaron G Schmidt; Xuling Zhu; Jared D Pitts; Jinhua Wang; Supanee Potisopon; Jianming Zhang; Amy Wojciechowski; Justin Jang Hann Chu; Nathanael S Gray; Priscilla L Yang
Journal:  Cell Chem Biol       Date:  2016-04-21       Impact factor: 8.116

Review 5.  Novel approaches to flavivirus drug discovery.

Authors:  Carolyn Botting; Richard J Kuhn
Journal:  Expert Opin Drug Discov       Date:  2012-03-22       Impact factor: 6.098

6.  In Silico Drug Discovery for Treatment of Virus Diseases.

Authors:  Shikha Joon; Rajeev K Singla; Bairong Shen
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

7.  Antibody Binding Modulates Conformational Exchange in Domain III of Dengue Virus E Protein.

Authors:  Adolfo H Moraes; Luca Simonelli; Mattia Pedotti; Fabio C L Almeida; Luca Varani; Ana P Valente
Journal:  J Virol       Date:  2015-12-04       Impact factor: 5.103

8.  Inhibition of Flaviviruses by Targeting a Conserved Pocket on the Viral Envelope Protein.

Authors:  Melissanne de Wispelaere; Wenlong Lian; Supanee Potisopon; Pi-Chun Li; Jaebong Jang; Scott B Ficarro; Margaret J Clark; Xuling Zhu; Jenifer B Kaplan; Jared D Pitts; Thomas E Wales; Jinhua Wang; John R Engen; Jarrod A Marto; Nathanael S Gray; Priscilla L Yang
Journal:  Cell Chem Biol       Date:  2018-06-21       Impact factor: 8.116

Review 9.  Small-Molecule Inhibition of Viral Fusion Glycoproteins.

Authors:  Han-Yuan Liu; Priscilla L Yang
Journal:  Annu Rev Virol       Date:  2021-07-01       Impact factor: 10.431

10.  Sulfated polysaccharide, curdlan sulfate, efficiently prevents entry/fusion and restricts antibody-dependent enhancement of dengue virus infection in vitro: a possible candidate for clinical application.

Authors:  Koji Ichiyama; Sindhoora Bhargavi Gopala Reddy; Li Feng Zhang; Wei Xin Chin; Tegshi Muschin; Lars Heinig; Youichi Suzuki; Haraprasad Nanjundappa; Yoshiyuki Yoshinaka; Akihide Ryo; Nobuo Nomura; Eng Eong Ooi; Subhash G Vasudevan; Takashi Yoshida; Naoki Yamamoto
Journal:  PLoS Negl Trop Dis       Date:  2013-04-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.